Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationActive Not Recruiting
NCT06096337NAUpdated Jul 27, 2026
Sponsor: Boston Scientific Corporation
Persistent Atrial Fibrillation
United States, Australia, Austria, Belgium, Canada +8 more
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentRecruiting
NCT06589804Phase 3Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hypopharyngeal Squamous Cell Carcinoma · Metastatic Laryngeal Squamous Cell Carcinoma · Metastatic Oral Cavity Squamous Cell Carcinoma
United States
POLARx Post Approval Study (POLARx PAS)Completed
NCT06170606NAUpdated Jul 27, 2026
Sponsor: Boston Scientific Corporation
Paroxysmal Atrial Fibrillation
United States
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaRecruiting
NCT07129993Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Daiichi Sankyo
Urothelial Cancer · Bladder Cancer
United States, Austria, China, France, Germany +2 more
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRecruiting
NCT06316297Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Sanofi Pasteur, a Sanofi Company
Acne
United States, Australia, Canada, Puerto Rico
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab AdizutecanRecruiting
NCT07196644Phase 2Updated Jul 27, 2026
Sponsor: AbbVie
Solid Tumors Harboring MET Amplification
United States, Israel, Japan, South Korea, Spain
Randomized Study of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot SurgeryCompleted
NCT07052721NAUpdated Jul 27, 2026
Sponsor: University of California, San Diego
Rotator Cuff Tears · Shoulder Injuries · Hallux Valgus · Ankle Arthropathy
United States
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Active Not Recruiting
NCT07400653Phase 3Updated Jul 27, 2026
Sponsor: Pfizer
Obesity · Overweight and/or Obesity · Overweight · Diabetes, Type 2
United States, Argentina, Bulgaria, Canada, Czechia +6 more
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesRecruiting
NCT07415031Phase 2Updated Jul 27, 2026
Sponsor: Mirati Therapeutics Inc.
Solid Tumors
United States, Australia, Belgium, Canada, China +15 more
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Recruiting
NCT06824467Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
United States, Argentina, Australia, Belgium, Brazil +23 more
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSACompleted
NCT06146101Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Incannex Healthcare Ltd
Obstructive Sleep Apnea
United States
Community-based Brain Health Program to Address Dementia RiskCompleted
NCT05529706NAUpdated Jul 27, 2026
Sponsor: Posit Science Corporation
Dementia · Alzheimer Disease
United States
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)Active Not Recruiting
NCT05250037N/AUpdated Jul 27, 2026
Sponsor: Fred Hutchinson Cancer Center
Bronchiolitis Obliterans Syndrome · Hematopoietic and Lymphoid Cell Neoplasm
United States
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Recruiting
NCT04777357Phase 3Updated Jul 27, 2026
Sponsor: AbbVie
Depression · Bipolar I Disorder
United States, Puerto Rico, Russia
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal MetastasesRecruiting
NCT06173401Phase 3Updated Jul 27, 2026
Sponsor: Stanford University
Spinal Metastases
United States
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg UlcersEnrolling By Invitation
NCT06453187NAUpdated Jul 27, 2026
Sponsor: Integra LifeSciences Corporation
Diabetic Foot Ulcer · Venous Leg Ulcer
United States
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo NodularisTerminated
NCT06527404Phase 3Updated Jul 27, 2026
Sponsor: Amgen
Prurigo Nodularis
United States, Argentina, Australia, Austria, Belgium +25 more
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Recruiting
NCT07137598Phase 2Updated Jul 27, 2026
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
United States, Argentina, Belgium, Brazil, Denmark +6 more
Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast CancerNot Yet Recruiting
NCT07729046Phase 2Updated Jul 27, 2026
Sponsor: University of California, San Diego
Metastatic Invasive Breast Cancer · Resistant Breast Cancer · ER+, HER2-, Metastatic Breast Cancer
United States
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)Active Not Recruiting
NCT04816604Phase 2Updated Jul 27, 2026
Sponsor: Gossamer Bio USA, Inc.
Pulmonary Arterial Hypertension
United States, Australia, Czechia, France, Germany +2 more
A Study of IDP-001 in Advanced or Metastatic Solid TumorsNot Yet Recruiting
NCT07602842Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: InduPro, Inc.
Advanced Solid Tumor · Metastatic Solid Tumor · Head and Neck Squamous Cell Carcinoma · Cutaneous Squamous Cell Carcinoma
United States
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and EquityRecruiting
NCT06183281NAUpdated Jul 27, 2026
Sponsor: University of California, San Francisco
Chronic Pain
United States
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Recruiting
NCT05125302Phase 3Updated Jul 27, 2026
Sponsor: AbbVie
Migraine
United States, Puerto Rico
Determining the Role of Social Reward Learning in Social AnhedoniaRecruiting
NCT05617898NAUpdated Jul 27, 2026
Sponsor: University of Alabama at Birmingham
Psychosis
United States
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaRecruiting
NCT07562152Phase 3Updated Jul 27, 2026
Sponsor: Immuneering Corporation
Pancreatic Cancer · Pancreatic Cancer Metastatic · PDAC · PDAC - Pancreatic Ductal Adenocarcinoma
United States, Australia

Previous page Next page